Literature DB >> 10470574

Comparison of different methods for dead space measurements in ventilated newborns using CO2-volume plot.

U Wenzel1, R R Wauer, G Schmalisch.   

Abstract

OBJECTIVE: The aim of the study was to test the applicability of Ventrak 1550/Capnogard 1265 (V-C) for respiratory dead space (VD) measurement and to determine anatomic (VDana), physiologic (VDphys), and alveolar dead spaces (VDalv) in ventilated neonates.
DESIGN: Prospective study.
SETTING: Neonatal intensive care unit. PATIENTS: 33 investigations in 22 ventilated neonates; median gestational age 34.5 weeks (range 27-41), median birthweight 2658 g (range 790-3940).
METHOD: The single-breath CO2 test (SBT-CO2) and transcutaneous partial pressure of carbon dioxide (PCO2) were recorded simultaneously and VD was determined (1) automatically (V-C software), (2) by interactive analysis of the PCO2 volume plot, and (3) manually by Bohr/Enghoff equations using data obtained by V-C.
RESULTS: VD measurements were possible in all cases by method 3 but not possible by methods 1 and 2 in 22 of 33 investigations (67%), especially in preterm neonates, because of disturbed signals. V.Dana/kg (1.6 +/- 0.6 ml/kg, mean +/- SD), VDana/tidal volume (VT) (0.36 +/- 0.09) were lower compared to published data in spontaneously breathing infants, whereas VDphys/kg (2.3 +/- 0.9 ml/kg) and VDphys/VT (0.50 +/- 0.12) are comparable to data obtained from the literature. Five minutes after insertion of the sensor (dead space 2.6 ml) into the ventilatory circuit, the transcutaneous PCO2 rose above baseline for 3.2% (patients > 2500 g) and 5.7% (patients < 2500 g). The time necessary for one analysis was 50-60 min.
CONCLUSION: In ventilated newborns, dead space measurements were possible only in one-third by SBT-CO2, but in all cases by Bohr/Enghoff equations. Improved software could further reduce the time needed for one analysis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10470574     DOI: 10.1007/s001340050933

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  8 in total

Review 1.  Deadspace ventilation: a waste of breath!

Authors:  Pratik Sinha; Oliver Flower; Neil Soni
Journal:  Intensive Care Med       Date:  2011-03-11       Impact factor: 17.440

2.  Prediction of prolonged ventilator dependence in preterm infants.

Authors:  Kamal Ali; Sabena Kagalwalla; Iram Cockar; Emma E Williams; Kentaro Tamura; Theodore Dassios; Anne Greenough
Journal:  Eur J Pediatr       Date:  2019-05-11       Impact factor: 3.183

3.  The influence of physiotherapy and suction on respiratory deadspace in ventilated children.

Authors:  Eleanor Main; Janet Stocks
Journal:  Intensive Care Med       Date:  2004-05-08       Impact factor: 17.440

4.  Reproducibility of the respiratory dead space measurements in mechanically ventilated children using the CO2SMO monitor.

Authors:  Y Riou; F Leclerc; V Neve; L Dupuy; O Noizet; S Leteurtre; A Sadik
Journal:  Intensive Care Med       Date:  2004-05-11       Impact factor: 17.440

5.  The effect of changing ventilator settings on indices of ventilation inhomogeneity in small ventilated lungs.

Authors:  G Schmalisch; H Proquitté; C C Roehr; R R Wauer
Journal:  BMC Pulm Med       Date:  2006-08-18       Impact factor: 3.317

6.  Volumetric capnography pre- and post-surfactant during initial resuscitation of premature infants.

Authors:  Emma E Williams; Theodore Dassios; Katie A Hunt; Anne Greenough
Journal:  Pediatr Res       Date:  2021-05-22       Impact factor: 3.953

Review 7.  Current methodological and technical limitations of time and volumetric capnography in newborns.

Authors:  Gerd Schmalisch
Journal:  Biomed Eng Online       Date:  2016-08-30       Impact factor: 2.819

8.  Reduction in minute alveolar ventilation causes hypercapnia in ventilated neonates with respiratory distress.

Authors:  Masashi Zuiki; Yuki Naito; Kazumasa Kitamura; Shinichiro Tsurukawa; Utsuki Matsumura; Takuyo Kanayama; Hiroshi Komatsu
Journal:  Eur J Pediatr       Date:  2020-08-03       Impact factor: 3.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.